0001757499-25-000003.txt : 20251107 0001757499-25-000003.hdr.sgml : 20251107 20251107131832 ACCESSION NUMBER: 0001757499-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251107 DATE AS OF CHANGE: 20251107 EFFECTIVENESS DATE: 20251107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shuttle Pharmaceuticals Holdings, Inc. CENTRAL INDEX KEY: 0001757499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-563446 FILM NUMBER: 251461727 BUSINESS ADDRESS: STREET 1: 401 PROFESSIONAL DRIVE STREET 2: SUITE 260 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: (240) 403-4212 MAIL ADDRESS: STREET 1: 401 PROFESSIONAL DRIVE STREET 2: SUITE 260 CITY: GAITHERSBURG STATE: MD ZIP: 20879 D 1 primary_doc.xml X0708 D LIVE 0001757499 Shuttle Pharmaceuticals Holdings, Inc. 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD MARYLAND 20879 (240) 403-4212 DELAWARE None None Corporation true Christopher Cooper 401 Professional Drive Suite 260 Gaithersburg MD MARYLAND 20879 Executive Officer Director Chief Executive Officer George Scorsis 401 Professional Drive Suite 260 Gaithersburg MD MARYLAND 20879 Director Adam Chambers 401 Professional Drive Suite 260 Gaithersburg MD MARYLAND 20879 Director Angel Liriano 401 Professional Drive Suite 260 Gaithersburg MD MARYLAND 20879 Director Oleh Nabyt 401 Professional Drive Suite 260 Gaithersburg MD MARYLAND 20879 Director Sachin Pathigoda 401 Professional Drive Suite 260 Gaithersburg MD MARYLAND 20879 Director Timothy Lorber 401 Professional Drive Suite 260 Gaithersburg MD MARYLAND 20879 Executive Officer Chief Financial Officer Tyvin Rich 401 Professional Drive Suite 260 Gaithersburg MD MARYLAND 20879 Executive Officer Chief Clinical Officer Mira Jung 401 Professional Drive Suite 260 Gaithersburg MD MARYLAND 20879 Executive Officer Chief Scientific Officer Pharmaceuticals Decline to Disclose 06b false 2025-11-03 false true true false 0 WestPark Capital, Inc. 39914 None None 535 5th Avenue Floor 22 New York NY NEW YORK 10017 true 2500624 2499998 626 false 1 99999 0 0 false Shuttle Pharmaceuticals Holdings, Inc. /s/ Christopher Cooper Christopher Cooper Chief Executive Officer 2025-11-07